NO910669L - O-glycosylert igf-1. - Google Patents

O-glycosylert igf-1.

Info

Publication number
NO910669L
NO910669L NO91910669A NO910669A NO910669L NO 910669 L NO910669 L NO 910669L NO 91910669 A NO91910669 A NO 91910669A NO 910669 A NO910669 A NO 910669A NO 910669 L NO910669 L NO 910669L
Authority
NO
Norway
Prior art keywords
igf
glycosylert
glycosylated
expressed
obtaining
Prior art date
Application number
NO91910669A
Other languages
English (en)
Other versions
NO180636B (no
NO910669D0 (no
NO180636C (no
Inventor
Anna Sknottner-Lundin
Linda Fryklund
Paer Gellerfors
Original Assignee
Kabi Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabi Pharmacia Ab filed Critical Kabi Pharmacia Ab
Publication of NO910669L publication Critical patent/NO910669L/no
Publication of NO910669D0 publication Critical patent/NO910669D0/no
Publication of NO180636B publication Critical patent/NO180636B/no
Publication of NO180636C publication Critical patent/NO180636C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/65—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO910669A 1988-08-20 1991-02-19 Fremgangsmåte for fremstilling av et rent O-glycosylert IGF-1 NO180636C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819826A GB8819826D0 (en) 1988-08-20 1988-08-20 Glycosylated igf-1
PCT/EP1989/000972 WO1990002198A1 (en) 1988-08-20 1989-08-17 O-glycosylated igf-1

Publications (4)

Publication Number Publication Date
NO910669L true NO910669L (no) 1991-02-19
NO910669D0 NO910669D0 (no) 1991-02-19
NO180636B NO180636B (no) 1997-02-10
NO180636C NO180636C (no) 1997-05-21

Family

ID=10642464

Family Applications (1)

Application Number Title Priority Date Filing Date
NO910669A NO180636C (no) 1988-08-20 1991-02-19 Fremgangsmåte for fremstilling av et rent O-glycosylert IGF-1

Country Status (15)

Country Link
US (1) US5273966A (no)
EP (2) EP0429502A1 (no)
JP (1) JP2543998B2 (no)
AT (1) ATE109206T1 (no)
AU (1) AU623675B2 (no)
CA (1) CA1335802C (no)
DE (1) DE68917061T2 (no)
DK (1) DK175360B1 (no)
ES (1) ES2060778T3 (no)
FI (1) FI102282B1 (no)
GB (1) GB8819826D0 (no)
IE (1) IE65096B1 (no)
NO (1) NO180636C (no)
NZ (1) NZ230383A (no)
WO (1) WO1990002198A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8920381D0 (en) * 1989-09-08 1989-10-25 Greater Glasgow Health Board Treatment of insulin-resistant diabetes
US5612198A (en) * 1990-09-04 1997-03-18 The Salk Institute Production of insulin-like growth factor-1 in methylotrophic yeast cells
US5231178A (en) * 1991-01-16 1993-07-27 The Salk Institute Biotechnology/Industrial Associates, Inc. Method for the purification of intact, correctly-folded insulin-like growth factor-1
AU661844B2 (en) * 1991-04-01 1995-08-10 Merck Sharp & Dohme Corp. Genes which influence (pichia) proteolytic activity, and uses therefor
SG46612A1 (en) * 1992-12-02 1998-02-20 Hoechst Ag Process for obtaining proinsulin in processing correctly linked cystine bridges
SE9402332D0 (sv) * 1994-07-01 1994-07-01 Pharmacia Ab Igf-1
US7833513B2 (en) 2004-12-03 2010-11-16 Rhode Island Hospital Treatment of Alzheimer's Disease
CL2007001614A1 (es) * 2006-06-09 2008-08-08 Novartis Ag Polipeptido que comprende una proteina del precursor del factor de crecimiento tipo insulina, igf-1 humana, en la cual la escision del peptido e mediante una proteasa se reduce a traves de la modificacion de la proteina del precursor; y su uso para t
EP2494050A4 (en) * 2009-10-30 2013-10-30 Merck Sharp & Dohme GRANULOCYTIC COLONY STIMULATING FACTOR MADE IN GLYCOENGINEERED PICHIA PASTORIS
US20100172865A1 (en) * 2010-03-18 2010-07-08 Shantha Totada R Methods of enhancing hair growth
US8691771B2 (en) 2010-05-21 2014-04-08 Merrimack Pharmaceuticals, Inc. Bi-specific fusion proteins for tissue repair
JP2016535080A (ja) 2013-10-02 2016-11-10 ノバルティス アーゲー 療法における使用のためのインスリン様成長因子模倣物
CA3000742A1 (en) 2015-10-02 2017-04-06 Silver Creek Pharmaceuticals, Inc. Bi-specific therapeutic proteins for tissue repair

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE95236T1 (de) * 1983-04-25 1993-10-15 Chiron Corp Hybrid-dns-synthesis von reifen insulinaehnlichen wachstumsfaktoren.

Also Published As

Publication number Publication date
NO180636B (no) 1997-02-10
DK29491D0 (da) 1991-02-20
GB8819826D0 (en) 1988-09-21
JP2543998B2 (ja) 1996-10-16
DK29491A (da) 1991-04-19
IE65096B1 (en) 1995-10-04
CA1335802C (en) 1995-06-06
WO1990002198A1 (en) 1990-03-08
NO910669D0 (no) 1991-02-19
ES2060778T3 (es) 1994-12-01
NO180636C (no) 1997-05-21
AU4051889A (en) 1990-03-23
DE68917061D1 (de) 1994-09-01
ATE109206T1 (de) 1994-08-15
AU623675B2 (en) 1992-05-21
FI102282B (fi) 1998-11-13
EP0360411B1 (en) 1994-07-27
DK175360B1 (da) 2004-09-13
US5273966A (en) 1993-12-28
FI910795A0 (fi) 1991-02-19
DE68917061T2 (de) 1994-11-17
JPH05505514A (ja) 1993-08-19
IE892652L (en) 1990-02-20
NZ230383A (en) 1992-01-29
EP0360411A1 (en) 1990-03-28
FI102282B1 (fi) 1998-11-13
EP0429502A1 (en) 1991-06-05

Similar Documents

Publication Publication Date Title
ATE246246T1 (de) Herstellung von hämoglobin und analogen davon in nicht-erythrozytzellen
ATE122357T1 (de) Polypeptide mit hormonwachstumsbefreiender wirkung.
FI851336A0 (fi) Ny fysiologiskt aktiv human polypeptid.
AU6733487A (en) Mammalian interleukin-4
DE68917061D1 (de) O-glycosylierter IGF-1.
DE68929551D1 (de) Menschliche DNase
ATE140483T1 (de) Natürlicher killerzellen-stimulationsfaktor
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
ATE56728T1 (de) Neue polypeptide mit alpha-amylase-hemmender wirkung, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
ATE96671T1 (de) Verwendung von tetrahydrocortisol in der therapie von glaukom.
FI880453A7 (fi) Nukutusainekoostumus ja menetelmä sen käyttämiseksi.
IL80562A0 (en) Recombinant human lysozyme,its preparation by recombinant dna technology and pharmaceutical compositions containing it
DE69518152D1 (de) Flüssige beta-interferon formulierungen
ATE73462T1 (de) Hirudin-variante, deren verwendung und herstellung.
FI893587L (fi) Menetelmä ei-glykosyloidun rekombinantti-humaani-IL2:n valmistamiseksi sen pelkistyneessä muodossa
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
ATE45675T1 (de) Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DK207388D0 (da) Nitrogenholdige, cycloaliphatiske forbindelser med en aminosyregruppe samt en pyridingruppe
AU3327789A (en) Expression of the hiv 24 kda 24 gag protein in methylotrophic yeast
FI891695A7 (fi) Lohen kasvuhormoonin ilmentäminen sukuun Pichia kuuluvassa metylotroofisessa hiivassa
SE8802685D0 (sv) Stol
DE3687042D1 (de) Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.